Good Health Can’t Wait.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Good</strong> <strong>Health</strong> <strong>Can’t</strong> <strong>Wait</strong>.<br />
Dr. Reddy’s Laboratories Limited<br />
NOTES TO FINANCIAL STATEMENTS<br />
(All amounts in Indian Rupees millions, except share data and where otherwise stated)<br />
2.27: RELATED PARTY DISCLOSURES (CONTINUED)<br />
PARTICULARS<br />
FOR THE YEAR ENDED<br />
31MARCH 2015<br />
FOR THE YEAR ENDED<br />
31MARCH 2014<br />
xvi. Rental deposit paid to: <br />
Relatives of key management personnel: <br />
G Mallika Reddy - 2<br />
G V Sanjana Reddy - 2<br />
Total - 4<br />
<br />
xvii. Remuneration to key management personnel (1) (2) 450 405<br />
(1)<br />
The above amounts do not include stock compensation expense and the remuneration<br />
of key management personnel employed by Company’s subsidiaries.<br />
(2)<br />
In addition to the above, the Company has accrued an amount of ` 51 towards a long<br />
term incentive plan, for the services rendered by key management personnel during<br />
the year ended 31 March 2015. Refer to Note 2.37 for further details.<br />
<br />
xviii. Investment made/(disposed) in subsidiaries during the year: <br />
Dr. Reddy’s Bio-Sciences Limited 200 -<br />
Dr. Reddy’s Laboratories SA - 10,564<br />
Reddy Pharma Iberia SA - 245<br />
Lacock Holdings Limited - (16,146)<br />
Dr. Reddy’s Laboratories (Proprietary) Limited - (512)<br />
Dr. Reddy’s Laboratories Inc. - (175)<br />
OOO Dr. Reddy’s Laboratories Limited - (72)<br />
Dr. Reddy’s Laboratories (Australia) Pty. Limited - (36)<br />
Total 200 (6,132)<br />
<br />
xix. Provision made for other than temporary diminution in the value of non current<br />
investments:<br />
<br />
<br />
Reddy Pharma Iberia SA - 245<br />
Total - 245<br />
<br />
xx. Investments in / (redemption of) preference shares: <br />
Aurigene Discovery Technologies Limited - (147)<br />
<br />
xxi. Loans and advances given to including accrued interest/(repaid by) subsidiaries and step<br />
down subsidiaries, net:<br />
<br />
<br />
Industrias Quimicas Falcon de Mexico S.A. de C.V. - 696<br />
Reddy Pharma Iberia SA - (245)<br />
Dr. Reddy’s Laboratories (Australia) Pty Limited - (442)<br />
DRL Impex Limited (1,286) (548)<br />
Dr. Reddy’s Laboratories Romania SRL (22) -<br />
Total (1,308) (539)<br />
xxii. Trade advances given to / (settled by) Ecologic Chemicals Limited - (2)<br />
<br />
xxiii. Provision made / (reversed) for loans given to subsidiary and step down subsidiaries: <br />
DRL Impex Limited 176 (280)<br />
Reddy Pharma Iberia SA - (245)<br />
Reddy Antilles N.V. - 147<br />
Total 176 (378)<br />
144
Change language